Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

11.0K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.0K
Amyloid Fibrils03:03

Amyloid Fibrils

6.0K
6.0K
Neural Regulation01:37

Neural Regulation

41.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National workshop on non-mammalian models in research with emphasis on the 3Rs principle.

ALTEX·2026
Same author

Erratum to National Workshop on Alternatives to Higher Animals in Toxicology and Biomedical Science.

ALTEX·2025
Same author

National workshop on alternatives to higher animals in toxicology and biomedical science.

ALTEX·2024
Same author

Drosophila melanogaster a Versatile Model of Parkinson's Disease.

CNS & neurological disorders drug targets·2021
Same author

Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.

CNS & neurological disorders drug targets·2021
Same author

Effect of capsaicin on the oxidative stress and dopamine content in the transgenic Drosophila model of Parkinson's disease.

Acta biologica Hungarica·2018

Related Experiment Video

Updated: Nov 8, 2025

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
09:32

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

8.8K

Does Human Alpha-Synuclein Behave Like Prions?

Yasir H Siddique1

  • 1Department of Zoology, Drosophila Transgenic Laboratory, Section of Genetics, Faculty of Life Sciences, Aligarh Muslim University, Aligarh-202002, Uttar Pradesh, India.

CNS & Neurological Disorders Drug Targets
|April 21, 2021
PubMed
Summary

Alpha-synuclein protein aggregates may function as prions, contributing to Parkinson's Disease progression. This review explores the prion-like nature of alpha-synuclein in neurodegeneration.

Keywords:
Lewy bodiesParkinson's diseasehumanprionssynaptic vesicles.α-synuclein

More Related Videos

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

709
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.0K

Related Experiment Videos

Last Updated: Nov 8, 2025

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
09:32

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

8.8K
Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

709
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.0K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Protein Chemistry

Background:

  • Alpha-synuclein (α-synuclein) is a protein primarily found in the brain, involved in synaptic vesicle movement.
  • Overexpression of α-synuclein leads to Lewy body formation, damaging dopaminergic neurons.
  • This damage is implicated in the pathogenesis of Parkinson's Disease (PD).

Purpose of the Study:

  • To review and present evidence on the prion-like characteristics of α-synuclein.
  • To elucidate the role of α-synuclein in the context of prion diseases.

Main Methods:

  • Literature review of studies investigating α-synuclein aggregation and propagation.
  • Analysis of research on protein misfolding and prion-like behavior.
  • Synthesis of findings related to α-synuclein's role in Parkinson's Disease.

Main Results:

  • Evidence suggests that aggregated α-synuclein exhibits prion-like properties.
  • These properties include the ability to seed and propagate misfolding in other α-synuclein molecules.
  • This prion-like mechanism is a key factor in the spread of pathology in Parkinson's Disease.

Conclusions:

  • Alpha-synuclein aggregates possess characteristics consistent with prions.
  • Understanding α-synuclein as a prion is crucial for developing effective Parkinson's Disease therapies.
  • Further research into the prion-like behavior of α-synuclein may unlock new therapeutic strategies.